European health data study for rare diseases
Part of Heart & circulation, Lungs & breathing clinical trials.
This trial combines health information from European research groups to study rare diseases. It looks at data from people who agreed to participate in these studies, which may help find better ways to diagnose or treat rare conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were part of a health study led by one of the European MORPHEUS project partners.
- You gave permission for your health data to be used in research.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is a “registry” study that collects information about people who have a confirmed blood clot in a vein, lung, or a superficial vein. It may help doctors understand outcomes over time, especially what happens in the first few months after diagnosis.
This trial tests a new computer tool that helps doctors decide whether you likely have a blood clot in your leg or lung. If you have symptoms and are not already on blood thinners, you may be able to join.
This study follows patients who have had a blood clot in their leg or lung to learn more about their health over time. It helps doctors understand how to better care for people with blood clots.
This study is building a registry of people with rare blood diseases. By joining, you help doctors learn more about these conditions and improve future care.
This study follows adults who may have a blood clot in the lung (pulmonary embolism) or leg (deep vein thrombosis), or who were found to have a clot by chance. It aims to improve how doctors diagnose, manage, and estimate risk, which may lead to better, more tailored care for you.
This trial is a registry (a database study) that tracks people with blood clots in the large veins of their legs or abdomen. It does not test any new drug or treatment, but helps doctors learn more about these conditions.
Hear when a new Venous Thromboembolism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.